Remote Monitored Systems PLC Pharm 2 Farm Update (3524F)
16 Novembre 2020 - 8:00AM
UK Regulatory
TIDMRMS
RNS Number : 3524F
Remote Monitored Systems PLC
16 November 2020
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
16 November 2020
Remote Monitored Systems plc ("RMS" or the "Company")
Pharm 2 Farm Update
The Company is pleased to issue the following update on its
wholly owned subsidiary Pharm 2Farm Limited ("P2F").
P2F is continuing to receive enquiries from prospective
distributors and purchasers for its viricidal mask and now
anticipates that future demand for its mask may outstrip the
production line capacity of five million viricidal face masks per
month.
To fulfil part of the anticipated excess demand, P2F expects to
supply its patented filter material, initially, to certain partner
mask manufacturers, until P2F has itself procured additional
production lines.
Over the weekend P2F signed binding heads of terms with a
manufacturer of surgical masks in Germany. The German manufacturer
will subcontract to supply complete masks to P2F to the P2F
specification and brand name, and also purchase P2F filter material
for their own brand masks. Under the heads of terms the
manufacturer will also develop and supply anti-viral C-Fold masks
using P2F filter material to extend P2F's market reach. The heads
of terms are subject to final contractual agreement between the
parties.
The Company will provide further updates to the market as
appropriate.
ENDS
ENQUIRIES:
Remote Monitored Systems plc
Trevor Brown (Executive Director) +41 7941 55384
Paul Ryan (Non-Executive Chairman) +32 475 754 148
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and joint broker
Stuart Gledhill
Caroline Rowe
Peterhouse Capital Limited +44 20 7469 0930
Joint broker
Lucy Williams
Duncan Vasey
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDEAFFSFLNEFAA
(END) Dow Jones Newswires
November 16, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Nanosynth (LSE:NNN)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Nanosynth (LSE:NNN)
Storico
Da Lug 2023 a Lug 2024